CAMBRIDGE, Mass. & BASEL, Switzerland & BEIJING–(BUSINESS WIRE)–$bgne #beigene–BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company today announced that the Company will participate in the J.P. Morgan 41st Annual Healthcare Conference on Monday, January 9, 2023 at 1:30 p.m. PT.
A live webcast can be accessed from the investors section of BeiGene�s website at http://ir.beigene.com. An archived replay will be available for 90 days following the event.
About BeiGene
BeiGene is a global biotechnology company that is developing and commercializing innovative and affordable oncology medicines to improve treatment outcomes and access for far more patients worldwide. With a broad portfolio, we are expediting development of our diverse pipeline of novel therapeutics through our internal capabilities and collaborations. We are committed to radically improving access to medicines for far more patients who need them. Our growing global team of more than 9,000 colleagues spans five continents, with administrative offices in Cambridge, U.S., & Basel, Switzerland & Beijing, China. To learn more about BeiGene, please visit www.beigene.com and follow us on Twitter at @BeiGeneGlobal.
Contacts
Investor:
Kevin Mannix
+1 240-410-0129
ir@beigene.com
Media:
Kyle Blankenship
+1 667- 351-5176
media@beigene.com
Connoisseurs of global cuisines are set to enjoy Horizon Heen StarWorld, the novel Central Macau…
TASHKENT, UZBEKISTAN - Media OutReach Newswire - 17 December 2025 - Wildberries, a leading digital…
SYDNEY, AUSTRALIA - NewsVoir - 17 December 2025 - Truecaller, the leading global communications platform,…
Dr. Hisham Badaruddin Appointed Chief Medical Officer as TSquared Health Integrates Medical, Biomarker, and AI…
TAIPEI, TAIWAN - Media OutReach Newswire - 17 December, 2025 - CyCraft Technology has been…
Ringing in the New Year, the extended collection promotes moderation and conscious drinking throughout the…
